A. V. van Delft

发表

Circadian periodicity of pituitary-adrenal function after p-chlorophenylalanine administration in the rat.

J. Kaplanski, P. G. Smelik, A. V. van Delft, 1973, The Journal of endocrinology.

Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor.

T. de Boer, W. Olijve, P. Vanderheyden, 1994, European journal of pharmacology.

The potential therapeutic role of the enantiomers and metabolites of mianserin.

R. Pinder, A. V. van Delft, A. van Delft, 1983, British journal of clinical pharmacology.

Effects of intra-arterial cannulation on blood platelet consumption in rats.

D. Meuleman, G. Vogel, A. V. van Delft, 1980, Thrombosis research.

Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.

T. de Boer, A. V. van Delft, F. Nefkens, 1996, The Journal of pharmacology and experimental therapeutics.

Animal models for anxiety and response to serotonergic drugs.

H. Berendsen, C. Broekkamp, F. Jenck, 1989, Psychopathology.

Re-introduction and evaluation of an accurate, high capacity bioassay for melanocyte-stimulating hormone using the skin of Anolis carolinensis in vitro.

F. Tilders, P. G. Smelik, A. V. van Delft, 1975, The Journal of endocrinology.

Alterations in local cerebral glucose utilization during chronic treatment with an ACTH 4-9 analog.

J. Mcculloch, P. Kelly, A. V. van Delft, 1982, European journal of pharmacology.

The effect of the potential antipsychotic ORG 5222 on local cerebral glucose utilization in freely moving rats.

T. de Boer, P. Room, J. Tonnaer, 1991, European journal of pharmacology.

A set of behavioural tests predicting antidepressant activity

H. Berendsen, J. S. de Graaf, H. van Riezen, 1985 .